Chat with us, powered by LiveChat
Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
Asia-Pacific Microwave Ablation Asia-Pacific Microwave Ablation
The Asia-Pacific Microwave Ablation Market was pegged at $15 million in 2013 and expected to be $31 million by 2018. Currently there are very few players in the Asia-Pacific Microwave Ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S).
Upcoming
European Microwave Ablation European Microwave Ablation
The European Microwave Ablation Market was pegged at $27 million in 2013 and expected to be $45 million by 2018. Currently there are very few players in European Microwave Ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S).
Upcoming
European Clinical Chemistry European Clinical Chemistry
Although earlier, Europe showed a negative growth rate in the clinical chemistry market, in some countries revenues grew compared to 2011. Germany commanded the largest share (20%) at an estimated $652.8 million in 2013 and is expected to reach $853.3 million by 2018, at a CAGR of 5.8% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report.
Upcoming
Asian Facial Interfaces Asian Facial Interfaces
The Asian Facial Interface market constitutes a growing market and a prime part of the Healthcare industry. Masks forms the major contributor in this market and is growing at a CAGR of 18.4% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report.
Upcoming
Americas Radiation Ablation Americas Radiation Ablation
The American Radiation Ablation Market, mainly driven by growing aging population, with increasing incidence, and prevalence of chronic diseases such as cancer and cardiovascular disorders, rapid acceptance of new medical technology, and well covered reimbursement system. The main companies operating in radiation ablation market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
Asia-Pacific Radiation Ablation Asia-Pacific Radiation Ablation
The Asia-Pacific Radiation Ablation Market was pegged at $559 million in 2013 and expected to be $899 million by 2018. It accounts for over 33% of the total ablation technologies market and expected to continue enjoying a major share in Radiation Ablation market. The main companies operating in Asia-Pacific radiation ablation market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
European Radiation Ablation European Radiation Ablation
The European Radiation Ablation Market was pegged at $864 million in 2013 and expected to be $1223 million by 2018. The main companies operating in European radiation ablation devices market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
Americas Radiofrequency Ablation Americas Radiofrequency Ablation
The Global Radiofrequency Ablation Market,  was pegged at $1160 million in 2013 and expected to be $2313 million by 2018. The key players in Radiofrequency Ablation sector are Covidien (Ireland), Boston Scientific (U.S.), Biosense Inc. (U.S.), St. Jude Medical (U.S.), AngioDynamics (U.S.) and Medtronic Inc. (U.S.).
Upcoming
Asia-Pacific Radiofrequency Ablation Asia-Pacific Radiofrequency Ablation
The Asia-Pacific Radiofrequency Ablation Market was pegged at $303 million in 2013 and expected to be $650 million by 2018. The key players in Asia-Pacific Radiofrequency ablation sector are Covidien (Ireland), Boston Scientific (U.S.), Biosense Inc. (U.S.), St. Jude Medical (U.S.), AngioDynamics (U.S.) and Medtronic Inc. (U.S.).
Upcoming
European Radiofrequency Ablation European Radiofrequency Ablation
The European Radiofrequency Ablation Market was pegged at $1160 million in 2013 and expected to be $2313 million by 2018. The key players in European radiofrequency ablation therapy sector are Covidien (Ireland), Boston Scientific (U.S.), Biosense Inc. (U.S.), St. Jude Medical (U.S.), AngioDynamics (U.S.) and Medtronic Inc. (U.S.).
Upcoming
Capnographs Capnographs
The “Global Capnographs Market”, mainly driven by increase chronically ill population, was pegged at $ 124 million in 2012 and expected to be $ 368 million by 2020, growing at a CAGR of 15.2%. The report analyzes the market of monitors by 2 segments such as Behind monitors and Handheld monitors. The main companies operating in Capnographs market and extensively covered in this report are Oridion (Covidien) (U.S.) is the global leader in the market, followed by Respironics (Philips) (Netherlands), Mindray (China), Welch Allyn (U.S.), and Smiths Medical (U.K.).  
Upcoming
Americas Ultrasound Ablation Americas Ultrasound Ablation
The American Ultrasound Ablation Market was pegged at $644 million in 2013 and expected to be $1155 million by 2018. The key players in ultrasound ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix.
Upcoming
Asia-Pacific Ultrasound Ablation Asia-Pacific Ultrasound Ablation
The Asia-Pacific Ultrasound Ablation Market was pegged at $259 million in 2013 and expected to be $535 million by 2018. The key players in Asia-Pacific Ultrasound Ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix.
Upcoming
European Ultrasound Ablation European Ultrasound Ablation
The European Ultrasound Ablation Market was pegged at $286 million in 2013 and expected to be $500 million by 2018. The key players in European Ultrasound Ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix.
Upcoming
Americas Thermal Ablation Americas Thermal Ablation
The American Thermal Ablation Market was pegged at $3097 million in 2013 and expected to be $5012 million by 2018. The main companies operating in thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others
Upcoming
Europe Coagulation Europe Coagulation
Europe holds the second position in the global coagulation market after the Americas. Germany commanded the largest share (20%) at an estimated $186.9 million in 2013 and is expected to reach $231.1 million by 2018, at a CAGR of 4.5% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report.
Upcoming
Asia-Pacific Thermal Ablation Asia-Pacific Thermal Ablation
The Asia-Pacific Thermal Ablation Market was pegged at $1533 million in 2013 and expected to be $2772 million by 2018. The main companies operating in Asia-Pacific Thermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.
Upcoming
European Thermal Ablation European Thermal Ablation
The European Thermal Ablation Market was pegged at $2132 million in 2013 and expected to be $3328 million by 2018. The main companies operating in European thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.
Upcoming
European Cardiac Rhythm Management Devices European Cardiac Rhythm Management Devices
The European Cardiac Rhythm Management Devices Market, mainly driven by Increasing Incidence of Lifestyle Diseases &Cardiovascular Diseases, was pegged at $ 3.16 billion in 2012 and expected to be $ 5.98 billion by 2018.The Cardiac Rhythm Management Devices Market by Geographies, Applications, Technologies, Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players  of this market have been considered in this report.
Upcoming
Asian Cardiac Rhythm Management Devices Asian Cardiac Rhythm Management Devices
The Asian Cardiac Rhythm Management Devices Market is growing at a fast pace.The Cardiac Rhythm Management Devices Market by Geographies, Applications, Technologies, Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players  of this market have been considered in this report.
Upcoming
2985 reports | Show
Connect With Us
US/CAN : +1-888-502-0539